Brief: Noxopharm Says A$1.45M Granted To Hudson Institute Of Medical Research
22/06/2022 02:31
June 22 (Reuters) - Noxopharm NOX.AX :
* A$1.45M GRANTED TO HUDSON INSTITUTE OF MEDICAL RESEARCH
FOR
RESEARCH INTO NOVEL THERAPEUTICS TO BLOCK INFLAMMATION
Source text for Eikon: ID:nASX4tPLSc
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer